Cholesterol Ester Storage Disease: Clinical Trials

3 trials for Cholesterol Ester Storage Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow Cholesterol Ester Storage Disease: new trials by email Literature Review of Cholesterol Ester Storage Disease trials Research Report on Cholesterol Ester Storage Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency
Sebelipase Alfa, Placebo - Lysosomal Acid Lipase Deficiency
Phase 3CompletedAlexion Pharmaceuticals, Inc.662013-01-222020-12-29
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency
Sebelipase alfa (SBC-102) - Lysosomal Acid Lipase Deficiency, Wolman Disease
Phase 2 / Phase 3CompletedAlexion Pharmaceuticals, Inc.92011-05-042019-01-30
Stem Cell Transplant for Inborn Errors of Metabolism
Stem Cell Transplant, Busulfan, Cyclophosphamide, Antithymocyte Globulin - Adrenoleukodystrophy, Metachromatic Leukodystrophy
Phase 2 / Phase 3CompletedMasonic Cancer Center, University of Minnesota1351995-01-012017-12-28

Narrower conditions

Wolman Disease (3)  ·  Niemann-Pick Diseases (2)  ·  Adrenoleukodystrophy (1)  ·  Chanarin-Dorfman Syndrome (1)  ·  Cirrhosis, Cryptogenic (1)  ·  Fucosidosis (1)  ·  Gangliosidosis, GM1 (1)  ·  Gaucher Disease (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Liver Diseases, Alcoholic (1)  ·  Lysosomal Storage Diseases (1)  ·  Neuronal Ceroid-Lipofuscinoses (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Infant, Newborn, Diseases (3)  ·  Lipid Metabolism Disorders (3)  ·  Lipid Metabolism, Inborn Errors (3)  ·  Lipidoses (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Histiocytosis (2)

Interventions

Sebelipase alfa (2)  ·  Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Stem Cell Transplantation (1)

Sponsors

Alexion Pharmaceuticals, Inc. (2)  ·  Masonic Cancer Center, University of Minnesota (1)

Countries

United States (3)  ·  France (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Florian Abel, MD (1)  ·  Paul Orchard, MD (1)

Results publications

PMID 21586746, PMID 24993530, PMID 34774639